Physician profile
Glen Kaiser
NPI 1801814082
$4,106.88
in general payments reported to CMS, 2019-2025
10 companies · $70.87 in 2025
The $70.87 reported for 2025 was more than what a typical Anesthesiology provider received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,599 · 2020: $1,700 · 2021: $88.55 · 2022: $58.53 · 2023: $334 · 2024: $255 · 2025: $70.87.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $660.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $660.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $3,200.00 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $356.55 | 2019-2025 | Bridion |
| Janssen Biotech, INC. | $227.83 | 2023-2024 | Stelara |
| Intercept Pharmaceuticals, INC. | $121.92 | 2023-2024 | Ocaliva |
| Takeda Pharmaceuticals U.S.A., INC. | $51.25 | 2023-2024 | Entyvio |
| Daiichi Sankyo INC. | $45.82 | 2023-2024 | Injectafer |
| Celgene Corporation | $33.59 | 2023 | Zeposia |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $24.69 | 2023 | Xifaxan |
| Avanos Medical | $22.96 | 2021 | |
| Regeneron Healthcare Solutions, INC. | $22.27 | 2024 | Dupixent |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Glen Kaiser listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.